Skip to main content
Date :

Antibodies are among the most valuable assets in any biopharma portfolio, and the patents protecting them are often fiercely contested. Securing patents that survive examination, opposition and litigation in Europe requires a clear understanding of the standards applied by the European Patent Office (EPO) and the courts.

In this webinar we will provide actionable insights to protect antibody innovations in Europe. We will revisit the EPO’s core approach to antibody inventions and share practical tips for drafting claims that stand up to scrutiny. We will highlight the principles for establishing inventive step, explore lifecycle management and next-generation antibody formats and review some of the latest case law from the EPO and the Unified Patent Court (UPC).

Topics covered include:

The EPO’s framework for patenting antibody-related inventions
Optimising claim formats for examination
Navigating inventive step, technical effect and post-filed data
Downstream inventions and lifecycle protection
Antibody-derived molecules: CARs, multispecifics and ADCs
Recent EPO case law highlights and developments at the UPC

This webinar will be presented by partners, Graham Lewis, Vicki Allen and Marc Wilkinson who are highly experienced in drafting patent applications for antibodies and other biologics, as well as prosecuting submissions at the EPO.

Venue and Location Information:
Online, and then on-demand